These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32405694)

  • 1. Daratumumab for refractory warm autoimmune hemolytic anemia.
    Jain A; Gupta DK
    Ann Hematol; 2021 May; 100(5):1351-1353. PubMed ID: 32405694
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
    Cheung WW; Hwang GY; Tse E; Kwong YL
    Haematologica; 2006 May; 91(5 Suppl):ECR13. PubMed ID: 16709521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment.
    Morselli M; Luppi M; Potenza L; Tonelli S; Dini D; Leonardi G; Donelli A; Narni F; Torelli G
    Blood; 2002 May; 99(9):3478-9. PubMed ID: 12001903
    [No Abstract]   [Full Text] [Related]  

  • 5. Warm autoimmune hemolytic anemia following recurrent mycoplasma pneumonia infections in a child with Down syndrome.
    Cassimos D; Bezirgiannidou Z; Pantelidou D; Christoforidis A; Chatzimichael A; Maritinis G
    Pediatr Hematol Oncol; 2008 Sep; 25(7):693-8. PubMed ID: 18850483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.
    Chao MP; Hong J; Kunder C; Lester L; Schrier SL; Majeti R
    Am J Hematol; 2015 Jan; 90(1):78-81. PubMed ID: 24942207
    [No Abstract]   [Full Text] [Related]  

  • 7. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
    Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
    J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease.
    Zaninoni A; Giannotta JA; Gallì A; Artuso R; Bianchi P; Malcovati L; Barcellini W; Fattizzo B
    Front Immunol; 2021; 12():649441. PubMed ID: 33732266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
    Piatek CI; Bocian H; Algaze S; Weitz IC; O'Connell C; Liebman HA
    Acta Haematol; 2020; 143(3):244-249. PubMed ID: 31665725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessory splenules in autoimmune hemolytic anemia.
    Logan A; Berube C; Gotlib J
    Am J Hematol; 2013 Feb; 88(2):156. PubMed ID: 23027373
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease.
    Cazenave JP; Gagnon JA; Girouard E; Bastarache A
    Can Med Assoc J; 1973 Oct; 109(8):748-9 passim. PubMed ID: 4746134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
    Sigler E; Shvidel L; Yahalom V; Berrebi A; Shtalrid M
    Transfusion; 2009 Jul; 49(7):1370-4. PubMed ID: 19374728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune hemolytic anemia].
    Wang L; Xu W; Li JY; Xie XY; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):425-8. PubMed ID: 17493362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe autoimmune hemolytic anemia associated with IgM warm auto-antibodies in primary Sjögren's syndrome.
    Shinoda K; Taki H; Hounoki H; Ogawa R; Sugiyama E; Tobe K
    Int J Rheum Dis; 2010 Feb; 13(1):94-6. PubMed ID: 20374393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
    Rieger MJ; Stolz SM; Ludwig S; Benoit TM; Bissig M; Widmer CC; Schwotzer R; Müller AM; Nair G; Hegemann I; Manz MG; Schanz U
    Br J Haematol; 2021 Sep; 194(5):931-934. PubMed ID: 34180543
    [No Abstract]   [Full Text] [Related]  

  • 18. Danazol for treatment of refractory autoimmune hemolytic anaemia.
    Tan AM; Lou J; Cheng HK
    Ann Acad Med Singap; 1989 Nov; 18(6):707-9. PubMed ID: 2624421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies.
    Webster D; Ritchie B; Mant MJ
    Am J Hematol; 2004 Apr; 75(4):258-9. PubMed ID: 15054824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient.
    Cooling L; Hugan S
    Transfusion; 2019 Dec; 59(12):3801-3802. PubMed ID: 31802512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.